BIODESIX INC's ticker is BDSX and the CUSIP is 09075X108. A total of 30 filers reported holding BIODESIX INC in Q3 2022. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,527,159 | +37.6% | 5,193,336 | +3.0% | 7.26% | +56.2% |
| Q2 2023 | $6,198,749 | +66027.0% | 5,039,633 | 0.0% | 4.65% | -36.7% |
| Q1 2023 | $9,374 | -19.1% | 5,039,633 | 0.0% | 7.34% | -10.4% |
| Q4 2022 | $11,591 | -99.6% | 5,039,633 | +112.6% | 8.19% | +286.2% |
| Q3 2022 | $3,010,000 | +2.8% | 2,370,071 | +30.8% | 2.12% | -0.5% |
| Q2 2022 | $2,929,000 | +38.4% | 1,811,412 | +44.6% | 2.13% | +39.8% |
| Q1 2022 | $2,117,000 | -68.1% | 1,252,753 | 0.0% | 1.52% | -64.3% |
| Q4 2021 | $6,627,000 | -27.0% | 1,252,753 | +13.4% | 4.27% | -30.9% |
| Q3 2021 | $9,083,000 | -37.8% | 1,104,953 | 0.0% | 6.18% | -29.2% |
| Q2 2021 | $14,596,000 | -35.0% | 1,104,953 | 0.0% | 8.73% | -34.5% |
| Q1 2021 | $22,442,000 | +0.7% | 1,104,953 | -0.0% | 13.32% | +3.8% |
| Q4 2020 | $22,278,000 | – | 1,105,083 | – | 12.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 2,370,071 | $3,010,000 | 2.12% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 378,023 | $480,000 | 0.08% |
| Endurant Capital Management LP | 130,136 | $165,000 | 0.05% |
| Cannell & Co. | 205,605 | $261,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 100,000 | $127,000 | 0.00% |
| CPWM, LLC | 15,497 | $20,000 | 0.00% |
| Column Capital Advisors, LLC | 5,700 | $7,000 | 0.00% |
| Allworth Financial LP | 55,853 | $71,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 124,070 | $157,000 | 0.00% |